Physician profile
Frederic J Gerges
NPI 1235310111
$20,765.70
in general payments reported to CMS, 2019-2025
34 companies · $1,682 in 2025
The $1,682 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,000 · 2020: $677 · 2021: $4,496 · 2022: $4,044 · 2023: $1,756 · 2024: $2,111 · 2025: $1,682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,201 · Travel and Lodging: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,200.86 |
| Travel and Lodging | $348.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrocision, INC. | $7,543.75 | 2019-2025 | Tenjet |
| Medtronic USA, INC. | $3,653.61 | 2019-2020 | |
| Medtronic, INC. | $2,861.77 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Boston Scientific Corporation | $1,351.45 | 2019-2025 | Wavewriter Alpha Prime 16, Avista Mri, Superion Indirect Decompression System |
| Abbott Laboratories | $1,253.12 | 2019-2025 | Proclaim, Eterna, Octrode |
| Abbvie INC. | $1,065.07 | 2021-2025 | |
| Lundbeck LLC | $511.08 | 2022-2025 | Vyepti |
| Painteq LLC | $278.46 | 2021-2024 | Painteq |
| Pfizer INC. | $224.04 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $221.00 | 2020 | |
| Relievant Medsystems, INC. | $198.08 | 2021-2022 | |
| Allergan, INC. | $191.21 | 2020-2022 | |
| Nevro Corp. | $180.67 | 2019-2021 | |
| Bioness INC | $167.45 | 2019 | |
| Si-Bone, INC. | $128.11 | 2019-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $124.76 | 2019-2024 | Prialt |
| Stimwave Technologies Incorporated | $93.20 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $87.62 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $87.13 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $70.92 | 2020 | |
| Stryker Corporation | $67.88 | 2024-2025 | Spinejack, Mild Device Kit |
| Vertos Medical, INC. | $59.99 | 2022-2023 | Mild Device Kit |
| Biohaven Pharmaceuticals, INC. | $42.53 | 2021 | |
| Flowonix Medical Incorporated | $40.50 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.84 | 2019 | |
| Biodelivery Sciences International, INC. | $32.95 | 2021 | |
| Globus Medical, INC. | $31.78 | 2025 | Senza |
| Ipsen Biopharmaceuticals, INC | $29.12 | 2019 | |
| Averitas Pharma INC. | $26.15 | 2025 | Qutenza |
| Almatica Pharma LLC | $23.06 | 2021 | |
| Amgen INC. | $22.82 | 2019 | |
| Spinal Simplicity, LLC | $21.01 | 2023 | Ha Minuteman G3-R |
| Spr Therapeutics, INC | $19.39 | 2022 | |
| Convatec INC. | $17.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$36,511.67 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederic Gerges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.